Viral serine/threonine protein kinases

Journal of Virology

Volumn 85, Issue 3, 2011, Pages 1158-1173

  Jacob, Thary ^a   Van Den Broeke, Céline ^a   Favoreel, Herman W ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; B1 KINASE; ELONGATION FACTOR; ELONGATION FACTOR 1 DELTA; INTERFERON; PROTEIN SERINE THREONINE KINASE; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG; US3 PROTEIN KINASE; VIRUS DNA; VIRUS PROTEIN;

ALPHAHERPESVIRINAE; BACULOVIRUS; CELL CULTURE; DNA REPLICATION; DNA VIRUS; DRUG TARGETING; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNE EVASION; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; VARICELLA ZOSTER VIRUS; VIRUS GENOME; VIRUS RELEASE; VIRUS REPLICATION; VIRUS VIRULENCE;

DNA VIRUSES; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; VIRAL PROTEINS;

DNA VIRUSES;

EID: 78651399013     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01369-10     Document Type: Short Survey

References (238)

1. Abendroth, A., I. Lin, B. Slobedman, H. Ploegh, and A. M. Arvin. 2001. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 75:4878-4888.
2. Advani, S. J., R. Brandimarti, R. R. Weichselbaum, and B. Roizman. 2000. The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes. J. Virol. 74:8-15.
3. Andrei, G., E. De Clercq, and R. Snoeck. 2009. Drug targets in cytomegalovirus infection. Infect. Disord. Drug Targets 9:201-222.
4. Ansari, A., and V. C. Emery. 1999. The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J. Virol. 73:3284-3291.
5. Aoki, T., et al. 2007. Genome sequences of three koi herpesvirus isolates representing the expanding distribution of an emerging disease threatening koi and common carp worldwide. J. Virol. 81:5058-5065.
6. Artenstein, A. W., and J. D. Grabenstein. 2008. Smallpox vaccines for biodefense: need and feasibility. Expert Rev. Vaccines 7:1225-1237.
7. Asai, R., et al. 2006. Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation- dependent process and phosphorylates the viral immediate-early protein BZLF1. J. Virol. 80:5125-5134.
8. Asai, R., T. Ohno, A. Kato, and Y. Kawaguchi. 2007. Identification of proteins directly phosphorylated by UL13 protein kinase from herpes simplex virus 1. Microbes Infect. 9:1434-1438. (Pubitemid 350019582)
9. Asano, S., et al. 1999. US3 protein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J. Gen. Virol. 80:51-56.
10. Baek, M. C., P. M. Krosky, and D. M. Coen. 2002. Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase. J. Virol. 76:11943-11952.
11. Baek, M. C., P. M. Krosky, Z. He, and D. M. Coen. 2002. Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase: importance of the P+5 position. J. Biol. Chem. 277:29593-29599.
12. Baek, M. C., P. M. Krosky, A. Pearson, and D. M. Coen. 2004. Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase. Virology 324:184-193.
13. Banham, A. H., D. P. Leader, and G. L. Smith. 1993. Phosphorylation of ribosomal proteins by the vaccinia virus B1R protein kinase. FEBS Lett. 321:27-31.
14. Banham, A. H., and G. L. Smith. 1992. Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology 191:803-812.
15. Beaud, G., R. Beaud, and D. P. Leader. 1995. Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase. J. Virol. 69:1819-1826.
16. Beaud, G., and R. Beaud. 2000. Temperature-dependent phosphorylation state of the H5R protein synthesised at the early stage of infection in cells infected with vaccinia virus ts mutants of the B1R and F10L protein kinases. Intervirology 43:67-70.
17. Benetti, L., and B. Roizman. 2004. Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. U. S. A. 101:9411-9416.
18. Benetti, L., and B. Roizman. 2007. In transduced cells, the US3 protein kinase of herpes simplex virus 1 precludes activation and induction of apoptosis by transfected procaspase 3. J. Virol. 81:10242-10248.
19. Besser, J., et al. 2003. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J. Virol. 77:5964-5974.
20. Betakova, T., E. J. Wolffe, and B. Moss. 1999. Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase. J. Virol. 73:3534-3543.
21. Biron, K. K., et al. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46:2365-2372.
22. Bischoff, D. S., and J. M. Slavicek. 1994. Identification and characterization of a protein kinase gene in the Lymantria dispar multinucleocapsid nuclear polyhedrosis virus. J. Virol. 68:1728-1736.
23. Black, E. P., N. Moussatche, and R. C. Condit. 1998. Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R. Virology 245:313-322.
24. Boyle, K. A., and P. Traktman. 2004. Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase. J. Virol. 78:1992-2005.
25. Britt, W. J., and D. Auger. 1986. Human cytomegalovirus virion-associated protein with kinase activity. J. Virol. 59:185-188. (Pubitemid 16062515)
26. Bruni, R., B. Fineschi, W. O. Ogle, and B. Roizman. 1999. A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and is recruited to the nucleus after infection. J. Virol. 73:3810-3817.
27. Brzozowska, A., M. Rychlowski, A. D. Lipinska, and K. Bienkowska-Szewczyk. 2010. Point mutations in BHV-1 US3 gene abolish its ability to induce cytoskeletal changes in various cell types. Vet. Microbiol. 143:8-13
28. Burma, S., B. P. Chen, M. Murphy, A. Kurimasa, and D. J. Chen. 2001. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276:42462-42467.
29. Cannon, J. S., F. Hamzeh, S. Moore, J. Nicholas, and R. F. Ambinder. 1999. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J. Virol. 73:4786-4793.
30. Cano-Monreal, G. L., J. E. Tavis, and L. A. Morrison. 2008. Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase. Virology 374:1-10.
31. Cano-Monreal, G. L., K. M. Wylie, F. Cao, J. E. Tavis, and L. A. Morrison. 2009. Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins. Virology 392:137-147.
32. Cartier, A., E. Broberg, T. Komai, M. Henriksson, and M. G. Masucci. 2003. The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B. Cell Death Differ. 10:1320-1328.
33. Cartier, A., T. Komai, and M. G. Masucci. 2003. The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad. Exp. Cell Res. 291:242-250.
34. Chabaud, S., et al. 2007. The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function. J. Gen. Virol. 88:384-394.
35. Chee, M. S., G. L. Lawrence, and B. G. Barrell. 1989. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70:1151-1160.
36. Chen, M. R., S. J. Chang, H. Huang, and J. Y. Chen. 2000. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J. Virol. 74:3093-3104.
37. Chiu, W. L., P. Szajner, B. Moss, and W. Chang. 2005. Effects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly. J. Virol. 79:8046-8056.
38. Chou, S., and G. I. Marousek. 2006. Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirus. Antimicrob. Agents Chemother. 50:3470-3472.
39. Coller, K. E., and G. A. Smith. 2008. Two viral kinases are required for sustained long distance axon transport of a neuroinvasive herpesvirus. Traffic 9:1458-1470.
40. Collett, M. S., and R. L. Erikson. 1978. Protein kinase activity associated with the avian sarcoma virus src gene product. Proc. Natl. Acad. Sci. U. S. A. 75:2021-2024.
41. Colunga, A. G., J. M. Laing, and L. Aurelian. 2010. The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins. Gene Ther. 17:315-327.
42. Condit, R. C., A. Motyczka, and G. Spizz. 1983. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 128:429-443.
43. Condit, R. C., and A. Motyczka. 1981. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology 113:224-241.
44. Conner, J. 1999. The unique N terminus of herpes simplex virus type 1 ribonucleotide reductase large subunit is phosphorylated by casein kinase 2, which may have a homologue in Escherichia coli. J. Gen. Virol. 80:1471-1476.
45. Coulter, L. J., H. W. Moss, J. Lang J. and D. J. McGeoch. 1993. A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted. J. Gen. Virol. 74:387-395.
46. Cunningham, C., et al. 1992. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J. Gen. Virol. 73:303-311.
47. Daikoku, T., et al. 1997. Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2. Virology 253:82-93.
48. Daikoku, T., Y. Yamashita, T. Tsurumi, K. Maeno, and Y. Nishiyama. 1993. Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2. Virology 197:685-694.
49. De Bolle, L., et al. 2002. Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir. Mol. Pharmacol. 62:714-721.
50. DeMasi, J., and P. Traktman. 2000. Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis. J. Virol. 74:2393-2405.
51. Derrien, M., A. Punjabi, M. Khanna, O. Grubisha, and P. Traktman. 1999. Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase. J. Virol. 73:7287-7296.
52. Deruelle, M., K. Geenen, H. J. Nauwynck, and H. W. Favoreel. 2007. A point mutation in the putative ATP binding site of the pseudorabies virus US3 protein kinase prevents Bad phosphorylation and cell survival following apoptosis induction. Virus Res. 128:65-70.
53. Deruelle, M. J., C. Van den Broeke, H. J. Nauwynck, T. C. Mettenleiter, and H. W. Favoreel. 2009. Pseudorabies virus US3- and UL49.5-dependent and -independent downregulation of MHC I cell surface expression in different cell types. Virology 395:172-181.
54. de Wind, N., J. Domen, and A. Berns. 1992. Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells. J. Virol. 66:5200-5209.
55. Doglio, L., A. De Marco, S. Schleich, N. Roos, and J. Krijnse Locker. 2002. The vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core. J. Virol. 76:9773-9786.
56. Eaton, H. E., J. Metcalf, E. Penny, V. Tcherepanov, C. Upton, and C. R. Brunetti. 2007. Comparative genomic analysis of the family Iridoviridae: re-annotating and defining the core set of iridovirus genes. Virol. J. 4:11.
57. Ehlers, A., J. Osborne, S. Slack, R. L. Roper, and C. Upton. 2002. Poxvirus orthologous clusters (POCs). Bioinformatics 18:1544-1545.
58. Eisfeld, A. J., S. E. Turse, S. A. Jackson, E. C. Lerner, and P. R. Kinchington. 2006. Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase. J. Virol. 80:1710-1723.
59. Eisfeld, A. J., M. B. Yee, A. Erazo, A. Abendroth, and P. R. Kinchington. 2007. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms. J. Virol. 81:9034-9049.
60. Erazo, A., and P. R. Kinchington. 2010. Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases. Curr. Top. Microbiol. Immunol. 342:79-98.
61. Evers, D. L., et al. 2002. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus. Antiviral Res. 56:61-72.
62. Fan, X., K. Thirunavukkarasu, and R. F. Weaver. 1996. Temperature-sensitive mutations in the protein kinase-1 (pk-1) gene of the Autographa californica nuclear polyhedrosis virus that block very late gene expression. Virology 224:1-9.
63. Favoreel, H. W., G. Van Minnebruggen, D. Adriaensen, and H. J. Nauwynck. 2005. Cytoskeletal rearrangements and cell extensions induced by the US3 kinase of an alphaherpesvirus are associated with enhanced spread. Proc. Natl. Acad. Sci. U. S. A. 102:8990-8995.
64. Federici, B. A., and R. H. Hice. 1997. Organization and molecular characterization of genes in the polyhedrin region of the Anagrapha falcifera multinucleocapsid NPV. Arch. Virol. 142:333-348.
65. Feederle, R., A. M. Mehl-Lautscham, H. Bannert, and H. J. Delecluse. 2009. The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J. Virol. 83:10877-10891.
66. Finnen, R. L., B. B. Roy, H. Zhang, and B. W. Banfield. 2010. Analysis of filamentous process induction and nuclear localization properties of the HSV-2 serine/threonine kinase Us3. Virology 397:23-33.
67. Frame, M. C., F. C. Purves, D. J. McGeoch, H. S. Marsden, and D. P. Leader. 1987. Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J. Gen. Virol. 68:2699-2704.
68. Fu, X., L. Tao, and X. Zhang. 2007. An HSV-2-based oncolytic virus deleted in the PK domain of the ICP10 gene is a potent inducer of apoptotic death in tumor cells. Gene Ther. 14:1218-1225.
69. Geenen, K., H. W. Favoreel, L. Olsen, L. W. Enquist, and H. J. Nauwynck. 2005. The pseudorabies virus US3 protein kinase possesses anti-apoptotic activity that protects cells from apoptosis during infection and after treatment with sorbitol or staurosporine. Virology 331:144-150.
70. Geiss, B. J., J. E. Tavis, L. M. Metzger, D. A. Leib, and L. A. Morrison. 2001. Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation. J. Virol. 75:10721-10729.
71. Gershburg, E., M. Marschall, K. Hong, and J. S. Pagano. 2004. Expression and localization of the Epstein-Barr virus-encoded protein kinase. J. Virol. 78:12140-12146.
72. Gershburg, S., L. Murphy, M. Marschall, and E. Gershburg. 2010. Key motifs in EBV (Epstein-Barr virus)-encoded protein kinase for phosphorylation activity and nuclear localization. Biochem. J. 431:227-235.
73. Giannopoulos, P. N., N. Nassoury, L. Lamontagne, C. Guertin, and K. K. Rashidan. 2005. Choristoneura fumiferana granulovirus pk-1: a baculoviral protein kinase. J. Biochem. Mol. Biol. 38:457-467.
74. Granzow, H., B. G. Klupp, W. Fuchs, J. Veits, N. Osterrieder, and T. C. Mettenleiter. 2001. Egress of alphaherpesviruses: comparative ultrastructural study. J. Virol. 75:3675-3684.
75. Hamirally, S., et al. 2009. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5:e1000275.
76. Hamza, M. S., et al. 2004. ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway. J. Biol. Chem. 279:38325-38330.
77. Hanks, S. K., and T. Hunter. 1995. Protein kinases 6: the eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9:576-596.
78. Hata, S., et al. 1999. Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect. 1:601-607.
79. He, Z., et al. 1997. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J. Virol. 71:405-411. (Pubitemid 26412306)
80. Howard, S. T., and G. L. Smith. 1989. Two early vaccinia virus genes encode polypeptides related to protein kinases. J. Gen. Virol. 70:3187-3201.
81. Hume, A. J., et al. 2008. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-799.
82. Hwang, S., et al. 2009. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 5:166-178.
83. Imai, T., K. Sagou, J. Arii, and Y. Kawaguchi. 2010. Effects of phosphorylation of herpes simplex virus 1 envelope glycoprotein B by Us3 kinase in vivo and in vitro. J. Virol. 84:153-162.
84. Isegawa, Y., et al. 2008. Characterization of the human herpesvirus 6 U69 gene product and identification of its nuclear localization signal. J. Virol. 82:710-718.
85. Jakob, N. J., K. Müller, U. Bahr, and G. Darai. 2001. Analysis of the first complete DNA sequence of an invertebrate iridovirus: coding strategy of the genome of Chilo iridescent virus. Virology 286:182-196.
86. Jarosinski, K. W., and N. Osterrieder. 2010. Further analysis of Marek's disease virus horizontal transmission confirms that UL44 (gC) and UL13 protein kinase activity are essential, while US2 is nonessential. J. Virol. 84:7911-7916.
87. Jerome, K. R., et al. 1999. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 73:8950-8957.
88. Kamil, J. P., and D. M. Coen. 2007. Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65. J. Virol. 81:10659-10668.
89. Kato, A., J. Arii, I. Shiratori, H. Akashi, H. Arase, and Y. Kawaguchi. 2009. Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface. J. Virol. 83:250-261.
90. Kato, A., et al. 2008. Identification of a physiological phosphorylation site of the herpes simplex virus 1-encoded protein kinase Us3 which regulates its optimal catalytic activity in vitro and influences its function in infected cells. J. Virol. 82:6172-6189.
91. Kato, A., et al. 2006. Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J. Virol. 80:1476-1486.
92. Kato, K., et al. 2001. Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J. Gen. Virol. 82:1457-1463.
93. Kato, K., et al. 2003. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine- 35, which regulates its coactivator function. J. Gen. Virol. 84:3381-3392.
94. Kawaguchi, Y., R. Bruni, and B. Roizman. 1997. Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J. Virol. 71:1019-1024.
95. Kawaguchi, Y., and K. Kato. 2003. Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2. Rev. Med. Virol. 13:331-340.
96. Kawaguchi, Y., et al. 2003. Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J. Virol. 77:2359-2368.
97. Kawaguchi, Y., T. Matsumura, B. Roizman, and K. Hirai. 1999. Cellular elongation factor 1delta is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses. J. Virol. 73:4456-4460.
98. Kawaguchi, Y., C. Van Sant, and B. Roizman. 1998. Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1. J. Virol. 72:1731-1736.
99. Kenyon, T. K., J. I. Cohen, and C. Grose. 2002. Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane. J. Virol. 76:10980-10993.
100. Kenyon, T. K., and C. Grose. 2010. VZV ORF47 serine protein kinase and its viral substrates. Curr. Top. Microbiol. Immunol. 342:99-111.
101. Kenyon, T. K., J. Lynch, J. Hay, W. Ruyechan, and C. Grose. 2001. Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J. Virol. 75:8854-8858.
102. Kinchington, P. R., J. K. Hougland, A. M. Arvin, W. T. Ruyechan, and J. Hay. 1992. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol. 66:359-366.
103. Klerkx, E. P., P. A. Lazo, and P. Askjaer. 2009. Emerging biological functions of the vaccinia-related kinase (VRK) family. Histol. Histopathol. 24:749-759.
104. Klupp, B., J. Altenschmidt, H. Granzow, W. Fuchs, and T. C. Mettenleiter. 2008. Glycoproteins required for entry are not necessary for egress of pseudorabies virus. J. Virol. 82:6299-6309.
105. Klupp, B. G., H. Granzow, and T. C. Mettenleiter. 2001. Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus. J. Gen. Virol. 82:2363-2371.
106. Koonin, E. V., and N. Yutin. 2010. Origin and evolution of eukaryotic large nucleo-cytoplasmic DNA viruses. Intervirology 53:284-292.
107. Kovacs, G. R., R. Rosales, J. G. Keck, and B. Moss. 1994. Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor. J. Virol. 68:3443-3447.
108. Kovacs, G. R., N. Vasilakis, and B. Moss. 2001. Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase. J. Virol. 75:4048-4055.
109. Krosky, P. M., M. C. Baek, and D. M. Coen. 2003. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914.
110. Krystof, V., and S. Uldrijan. 2010. Cyclin-dependent kinase inhibitors as anticancer drugs. Curr. Drug Targets 11:291-302.
111. Kuny, C. V., K. Chinchilla, M. R. Culbertson, and R. F. Kalejta. 2010. Cyclin-dependent kinase-like function is shared by the beta- and gamma-subset of the conserved herpesvirus protein kinases. PLoS Pathog. 6:e1001092.
112. Langelier, Y., et al. 1998. The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase. J. Biol. Chem. 273:1435-1443.
113. Lauzon, H. A., C. J. Lucarotti, P. J. Krell, Q. Feng, A. Retnakaran, and B. M. Arif. 2004. Sequence and organization of the Neodiprion lecontei nucleopolyhedrovirus genome. J. Virol. 78:7023-7035.
114. Leach, N., et al. 2007. Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. J. Virol. 81:10792-10803.
115. Leader, D. P. 1993. Viral protein kinases and protein phosphatases. Pharmacol. Ther. 59:343-389.
116. Leader, D. P., A. D. Deana, F. Marchiori, F. C. Purves, and L. A. Pinna. 1991. Further definition of the substrate specificity of the alpha-herpesvirus protein kinase and comparison with protein kinases A and C. Biochim. Biophys. Acta 1091:426-431.
117. Leader, D. P., and M. Katan. 1988. Viral aspects of protein phosphorylation. J. Gen. Virol. 69:1441-1464.
118. Lee, C. P., et al. 2008. Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J. Virol. 82:11913-11926.
119. Leopardi, R., C. Van Sant, and B. Roizman. 1997. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. U. S. A. 94:7891-7896.
120. Liang, L., and B. Roizman. 2008. Expression of gamma interferon-dependent genes is blocked independently by virion host shutoff RNase and by US3 protein kinase. J. Virol. 82:4688-4696.
121. Lin, S., and S. S. Broyles. 1994. Vaccinia protein kinase 2: a second essential serine/threonine protein kinase encoded by vaccinia virus. Proc. Natl. Acad. Sci. U. S. A. 91:7653-7657.
122. Lin, S., W. Chen, and S. S. Broyles. 1992. The vaccinia virus B1R gene product is a serine/threonine protein kinase. J. Virol. 66:2717-2723.
123. Littler, E., A. D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
124. Liu, W. J., et al. 2001. Cloning, characterization, and phylogenetic analysis of a shrimp white spot syndrome virus gene that encodes a protein kinase. Virology 289:362-377.
125. Long, M. C., V. Leong, P. A. Schaffer, C. A. Spencer, and S. A. Rice. 1999. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J. Virol. 73:5593-5604.
126. Maeda, N., H. Fan, and Y. Yoshikai. 2008. Oncogenesis by retroviruses: old and new paradigms. Rev. Med. Virol. 18:387-405.
127. Manning, G., D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. 2002. The protein kinase complement of the human genome. Science 298:1912-1934.
128. Margalit, A., A. Brachner, J. Gotzmann, R. Foisner, and Y. Gruenbaum. 2007. Barrier-to-autointegration factor: a BAFfling little protein. Trends Cell Biol. 17:202-208.
129. Marschall, M., et al. 2003. The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311:60-71.
130. Marschall, M., et al. 2005. Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J. Biol. Chem. 280:33357-33367.
131. McCraith, S., T. Holtzman, B. Moss, and S. Fields. 2000. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 97:4879-4884.
132. McFadden, G. 2010. Killing a killer: what next for smallpox? PLoS Pathog. 6:e1000727.
133. McGeoch, D. J., and A. J. Davison. 1986. Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res. 14:1765-1777.
134. Meignier, B., R. Longnecker, and B. Roizman. 1988. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. J. Infect. Dis. 158:602-614.
135. Meijer, L., et al. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536.
136. Meng, Q., et al. 2010. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J. Virol. 84:4534-4542.
137. Meng, Q., S. R. Hagemeier, C. V. Kuny, R. F. Kalejta, and S. C. Kenney. 2010. Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. J. Virol. 84:4524-4533.
138. Mercer, J., and P. Traktman. 2003. Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane. J. Virol. 77:8857-8871.
139. Mercer, J., and P. Traktman. 2005. Genetic and cell biological characterization of the vaccinia virus A30 and G7 phosphoproteins. J. Virol. 79:7146-7161. (Pubitemid 40677345)
140. Mettenleiter, T. C., B. G. Klupp, and H. Granzow. 2009. Herpesvirus assembly: an update. Virus Res. 143:222-234.
141. Michel, D., et al. 1999. Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation. J. Virol. 73:8898-8901. (Pubitemid 29441761)
142. Michel, D., and T. Mertens. 2004. The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host. Biochim. Biophys. Acta 1697:169-180.
143. Michel, D., et al. 1996. The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J. Virol. 70:6340-6346. (Pubitemid 26266854)
144. Milbradt, J., S. Auerochs, and M. Marschall. 2007. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J. Gen. Virol. 88:2642-2650.
145. Miller, L. K., M. J. Adang, and D. Browne. 1983. Protein kinase activity associated with the extracellular and occluded forms of the baculovirus Autographa californica nuclear polyhedrosis virus. J. Virol. 46:275-278.
146. Mishra, G., P. Chadha, I. Chaudhury, and R. H. Das. 2008. Inhibition of Autographa californica nucleopolyhedrovirus (AcNPV) polyhedrin gene expression by DNAzyme knockout of its serine/threonine kinase (pk1) gene. Virus Res. 135:197-201.
147. Mishra, G., P. Chadha, and R. H. Das. 2008. Serine/threonine kinase (pk-1) is a component of Autographa californica multiple nucleopolyhedrovirus (AcMNPV) very late gene transcription complex and it phosphorylates a 102 kDa polypeptide of the complex. Virus Res. 137:147-149.
148. Mishra, G., and R. H. Das. 2007. Characterization of a eukaryotic type serine/threonine kinase in Spodoptera litura nucleopolyhedrovirus-I (Splt-NPV-I). Virus Res. 128:126-134.
149. Mishra, G., H. K. Gautam, and R. H. Das. 2007. Serine/Threonine kinase dependent transcription from the polyhedrin promoter of SpltNPV-I. Biochem. Biophys. Res. Commun. 358:942-947.
150. Moffat, J. F., et al. 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. U. S. A. 95:11969-11974.
151. Morimoto, T., et al. 2009. Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2. J. Virol. 83:11624-11634.
152. Morrison, E. E., Y. F. Wang, and D. M. Meredith. 1998. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J. Virol. 72:7108-7114.
153. Mou, F., T. Forest, and J. D. Baines. 2007. US3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J. Virol. 81:6459-6470.
154. Mou, F., E. Wills, and J. D. Baines. 2009. Phosphorylation of the UL31 protein of herpes simplex virus 1 by the US3 encoded kinase regulates localization of the nuclear envelopment complex and egress of nucleocapsids. J. Virol. 83:5181-5191.
155. Muranyi, W., J. Haas, M. Wagner, G. Krohne, and U. H. Koszinowski. 2002. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297:854-857.
156. Murata, T., F. Goshima, T. Daikoku, H. Takakuwa, and Y. Nishiyama. 2000. Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells 5:1017-1027. (Pubitemid 32156745)
157. Murata, T., et al. 2002. Phosphorylation of cytokeratin 17 by herpes simplex virus type 2 US3 protein kinase. Microbiol. Immunol. 46:707-719.
158. Nezu, J., A. Oku, M. H. Jones, and M. Shimane. 1997. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45:327-331. (Pubitemid 27467623)
159. Ng, T. I., and C. Grose. 1992. Serine protein kinase associated with varicella-zoster virus ORF 47. Virology 191:9-18.
160. Ng, T. I., L. Keenan, P. R. Kinchington, and C. Grose. 1994. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol. 68:1350-1359.
161. Ng, T. I., W. O. Ogle, and B. Roizman. 1998. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 241:37-48.
162. Ng, T. I., C. Talarico, T. C. Burnette, K. Biron, and B. Roizman. 1996. Partial substitution of the functions of the herpes simplex virus 1 U(L)13 gene by the human cytomegalovirus U(L)97 gene. Virology 225:347-358.
163. Nichols, R. J., and P. Traktman. 2004. Characterization of three paralogous members of the mammalian vaccinia related kinase family. J. Biol. Chem. 279:7934-7946.
164. Nichols, R. J., M. S. Wiebe, and P. Traktman. 2006. The vaccinia-related kinases phosphorylate the N′ terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell 17:2451-2464.
165. Ogg, P. D., P. J. McDonell, B. J. Ryckman, C. M. Knudson, and R. J. Roller. 2004. The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 319:212-224.
166. Ogle, W. O., T. I. Ng, K. L. Carter, and B. Roizman. 1997. The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 235:406-413.
167. Overton, H., D. McMillan, L. Hope, and P. Wong-Kai-In. 1994. Production
168. Overton, H. A., D. J. McMillan, L. S. Klavinskis, L. Hope, A. J. Ritchie, and P. Wong-kai-in. 1992. Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion. Virology 190:184-192.
169. Park, J., D. Lee, T. Seo, J. Chung, and J. Choe. 2000. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase. J. Gen. Virol. 81:1067-1071.
170. Park, R., and J. D. Baines. 2006. Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J. Virol. 80:494-504.
171. Peri, P., et al. 2008. Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virol. J. 5:140.
172. Perkins, D., E. F. Pereira, and L. Aurelian. 2003. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J. Virol. 77:1292-1305.
173. Perkins, D., E. F. Pereira, M. Gober, P. J. Yarowsky, and L. Aurelian. 2002. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 76:1435-1449.
174. Petretti, C., and C. Prigent. 2005. The protein kinase resource: everything you always wanted to know about protein kinases but were afraid to ask. Biol. Cell 97:113-118.
175. Piroozmand, A., et al. 2004. Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon. Int. J. Mol. Med. 14:641-645.
176. Poon, A. P., H. Gu, and B. Roizman. 2006. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc. Natl. Acad. Sci. U. S. A. 103:9993-9998.
177. Poon, A. P., and B. Roizman. 2005. Herpes simplex virus 1 ICP22 regulates the accumulation of a shorter mRNA and of a truncated US3 protein kinase that exhibits altered functions. J. Virol. 79:8470-8479.
178. Poon, A. P., and B. Roizman. 2007. Mapping of key functions of the herpes simplex virus 1 U(S)3 protein kinase: the U(S)3 protein can form functional heteromultimeric structures derived from overlapping truncated polypeptides. J. Virol. 81:1980-1989.
179. Prichard, M. N., W. J. Britt, S. L. Daily, C. B. Hartline, and E. R. Kern. 2005. Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J. Virol. 79:15494-15502.
180. Prichard, M. N., et al. 1999. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J. Virol. 73:5663-5670.
181. Prichard, M. N., et al. 2008. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J. Virol. 82:5054-5067.
182. Punjabi, A., and P. Traktman. 2005. Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J. Virol. 79:2171-2190.
183. Purves, F. C., A. D. Deana, F. Marchiori, D. P. Leader, and L. A. Pinna. 1986. The substrate specificity of the protein kinase induced in cells infected with herpesviruses: studies with synthetic substrates [corrected] indicate structural requirements distinct from other protein kinases. Biochim. Biophys. Acta 889:208-215.
184. Purves, F. C., W. O. Ogle, and B. Roizman. 1993. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. U. S. A. 90:6701-6705.
185. Purves, F. C., and B. Roizman. 1992. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22. Proc. Natl. Acad. Sci. U. S. A. 89:7310-7314.
186. Rahaus, M., N. Desloges, and M. H. Wolff. 2007. Varicella-zoster virus requires a functional PI3K/Akt/GSK-3alpha/beta signaling cascade for efficient replication. Cell. Signal. 19:312-320.
187. Reddy, S. M., E. Cox, I. Iofin, W. Soong, and J. I. Cohen. 1998. Varicellazoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J. Virol. 72:8083-8088.
188. Reilly, L. M., and L. A. Guarino. 1994. The pk-1 gene of Autographa californica multinucleocapsid nuclear polyhedrosis virus encodes a protein kinase. J. Gen. Virol. 75:2999-3006.
189. Rempel, R. E., M. K. Anderson, E. Evans, and P. Traktman. 1990. Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J. Virol. 64:574-583.
190. Reynolds, A. E., et al. 2001. U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids. J. Virol. 75:8803-8817.
191. Reynolds, A. E., E. G. Wills, R. J. Roller, B. J. Ryckman, and J. D. Baines. 2002. Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids. J. Virol. 76:8939-8952.
192. Roizman, B., and P. E. Pellet. 2001. The family Herpesviridae: a brief introduction, p. 2381-2397. In D. M. Knipe et al. (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
193. Romaker, D., et al. 2006. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation. J. Med. Chem. 49:7044-7053.
194. Ryckman, B. J., and R. J. Roller. 2004. Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J. Virol. 78:399-412.
195. Schaap, A., et al. 2005. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J. Virol. 79:12921-12933.
196. Schang, L. M., et al. 2002. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. J. Virol. 76:7874-7882.
197. Schumacher, D., C. McKinney, B. B. Kaufer, and N. Osterrieder. 2008. Enzymatically inactive U(S)3 protein kinase of Marek's disease virus (MDV) is capable of depolymerizing F-actin but results in accumulation of virions in perinuclear invaginations and reduced virus growth. Virology 375:37-47.
198. Schumacher, D., B. K. Tischer, S. Trapp, and N. Osterrieder. 2005. The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J. Virol. 79:3987-3997.
199. Senkevich, T. G., E. V. Koonin, J. J. Bugert, G. Darai, and B. Moss. 1997. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 233:19-42.
200. Shibaki, T., T. Suzutani, I. Yoshida, M. Ogasawara, and M. Azuma. 2001. Participation of type I interferon in the decreased virulence of the UL13 gene-deleted mutant of herpes simplex virus type 1. J. Interferon Cytokine Res. 21:279-285.
201. Somogyi, T., S. Michelson, and M. J. Masse. 1990. Genomic location of a human cytomegalovirus protein with protein kinase activity (PK68). Virology 174:276-285.
202. Sullivan, V., et al. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358:162-164.
203. Szajner, P., A. S. Weisberg, and B. Moss. 2004. Physical and functional interactions between vaccinia virus F10 protein kinase and virion assembly proteins A30 and G7. J. Virol. 78:266-274.
204. Takashima, Y., H. Tamura, X. Xuan, and H. Otsuka. 1999. Identification of the US3 gene product of BHV-1 as a protein kinase and characterization of BHV-1 mutants of the US3 gene. Virus Res. 59:23-34.
205. Tamrakar, S., A. J. Kapasi, and D. H. Spector. 2005. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. J. Virol. 79:15477-15493.
206. Tan, K. B. 1975. Comparative study of the protein kinase associated with animal viruses. Virology 64:566-570.
207. Tanaka, M., Y. Nishiyama, T. Sata, and Y. Kawaguchi. 2005. The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0. Virology 341:301-312.
208. Tanaka, M., et al. 2002. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association. J. Virol. 76:1025-1032.
209. Tarakanova, V. L., et al. 2007. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1:275-286.
210. Tarakanova, V. L., E. Stanitsa, S. M. Leonardo, T. M. Bigley, and S. B. Gauld. 2010. Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo. Virology 405:50-61.
211. Tidona, C. A., and G. Darai. 1997. The complete DNA sequence of lymphocystis disease virus. Virology 230:207-216.
212. Traktman, P., M. K. Anderson, and R. E. Rempel. 1989. Vaccinia virus encodes an essential gene with strong homology to protein kinases. J. Biol. Chem. 264:21458-21461.
213. Traktman, P., A. Caligiuri, S. A. Jesty, K. Liu, and U. Sankar. 1995. Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J. Virol. 69:6581-6587.
214. Trofe, J., L. Pote, E. Wade, E. Blumberg, and R. D. Bloom. 2008. Maribavir: a novel antiviral agent with activity against cytomegalovirus. Ann. Pharmacother. 42:1447-1457.
215. Van den Broeke, C., M. Deruelle, H. J. Nauwynck, K. E. Coller, G. A. Smith, J. Van Doorsselaere, and H. W. Favoreel. 2009. The kinase activity of pseudorabies virus US3 is required for modulation of the actin cytoskeleton. Virology 385:155-160.
216. Van den Broeke, C., M. Radu, M. Deruelle, H. Nauwynck, C. Hofmann, Z. M. Jaffer, J. Chernoff, and H. W. Favoreel. 2009. Alphaherpesvirus US3-mediated reorganization of the actin cytoskeleton is mediated by group A p21-activated kinases. Proc. Natl. Acad. Sci. U. S. A. 106:8707-8712.
217. Van Hulten, M. C., and J. M. Vlak. 2001. Identification and phylogeny of a protein kinase gene of white spot syndrome virus. Virus Genes. 22:201-207.
218. Van Minnebruggen, G., H. W. Favoreel, L. Jacobs, and H. J. Nauwynck. 2003. Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown. J. Virol. 77:9074-9080.
219. van Zeijl, M., J. Fairhurst, E. Z. Baum, L. Sun, and T. R. Jones. 1997. The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231:72-80.
220. Vigne, S., et al. 2009. Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir. Antimicrob. Agents Chemother. 53:2579-2588.
221. Wagenaar, F., et al. 1995. The US3-encoded protein kinase from pseudorabies virus affects egress of virions from the nucleus. J. Gen. Virol. 76: 1851-1859.
222. Wagner, M., et al. 2000. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity. J. Virol. 74:10729-10736.
223. Walters, M. S., A. Erazo, P. R. Kinchington, and S. Silverstein. 2009. Histone deacetylases 1 and 2 are phosphorylated at novel sites during varicella-zoster virus infection. J. Virol. 83:11502-11513.
224. Walters, M. S., P. R. Kinchington, B. W. Banfield, and S. Silverstein. 2010. Hyperphosphorylation of histone deacetylase 2 by alphaherpesvirus US3 kinases. J. Virol. 84:9666-9676.
225. Wang, J. T., et al. 2009. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 83:1856-1869.
226. Wang, J. T., et al. 2005. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J. Gen. Virol. 86:3215-3225.
227. Wang, S., and S. Shuman. 1995. Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J. Virol. 69:6376-6388.
228. Webb, T. J., R. A. Litavecz, M. A. Khan, W. Du, J. Gervay-Hague, G. J. Renukaradhya, and R. R. Brutkiewicz. 2006. Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules. Eur. J. Immunol. 36:2595-2600.
229. Wiebe, M. S., and P. Traktman. 2007. Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication. Cell Host Microbe 1:187-197.
230. Wilson, M. E., and R. A. Consigli. 1985. Characterization of a protein kinase activity associated with purified capsids of the granulosis virus infecting Plodia interpunctella. Virology 143:516-525.
231. Wilson, M. E., and R. A. Consigli. 1985. Functions of a protein kinase activity associated with purified capsids of the granulosis virus infecting Plodia interpunctella. Virology 143:526-535.
232. Wisner, T. W., et al. 2009. Herpesvirus gB-induced fusion between the virion envelope and outer nuclear membrane during virus egress is regulated by the viral US3 kinase. J. Virol. 83:3115-3126.
233. Wolf, D. G., C. T. Courcelle, M. N. Prichard, and E. S. Mocarski. 2001. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc. Natl. Acad. Sci. U. S. A. 98:1895-1900.
234. Yang, P. W., S. S. Chang, C. H. Tsai, Y. H. Chao, and M. R. Chen. 2008. Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J. Gen. Virol. 89:884-895.
235. Yao, Z. Q., et al. 2001. Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting. Vaccine 19:1628-1635.
236. Yokota, S., et al. 2004. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 78:6282-6286.
237. Zhang, C. X., G. Wang, C. Hu, and X. F. Wu. 1997. Nucleotide sequence analysis of HaSNPV protein kinase. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 29:322-326.
238. Zimmermann, A., D. Michel, I. Pavić, W. Hampl, A. Lüske, J. Neyts, E. De Clercq, and T. Mertens. 1997. Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses. Antiviral Res. 36:35-42.